FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2883460805> ?p ?o ?g. }

• W2883460805 endingPage "101042831879036" @default.
• W2883460805 startingPage "101042831879036" @default.
• W2883460805 abstract "Macrophage-colony stimulating factor, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 may play an important role in malignant processes. The aim of this study was to investigate the diagnostic power of those parameters (serological biomarkers) in comparison to cancer antigen 125 and squamous cell carcinoma antigen in cervical cancer patients and in relation to the control groups. The study included 100 cervical cancer patients, 50 patients with cervical ectropion and 50 healthy women. Plasma levels of tested parameters were determined by enzyme-linked immunosorbent assay, cancer antigen 125, and squamous cell carcinoma antigen by chemiluminescent microparticle immunoassay. Plasma levels of all parameters in the total cancer group showed statistical significance (in all cases p < 0.05). In stage I of cancer only medial supraclavicular fossa and tissue inhibitor of metalloproteinase-1, in stage II all the tested parameters and cancer antigen 125, and in stage III + IV macrophage-colony stimulating factor, matrix metalloproteinase-9, and cancer antigen 125 showed statistical significance when compared to the healthy volunteers group. Macrophage-colony stimulating factor showed the highest value of sensitivity from all tested parameters (I: 56.25%, II: 72.73%, III + IV: 77.14% and 69% in total cervical cancer group). The highest specificity was obtained by matrix metalloproteinase-9 (94%). Positive predictive values were highest also for matrix metalloproteinase-9 (I: 82.35%, II: 84.21%, III + IV: 88% and 94.55% in total cervical cancer group), negative predictive values for macrophage-colony stimulating factor (I: 75.44%, II: 82.69%, III + IV: 87.5% and 58.11% in total cervical cancer group) and tumor markers. In the total cervical cancer group, all tested parameters showed statistically significant areas under receiver operating characteristic curve, but maximum range was obtained for the combination macrophage-colony stimulating factor + squamous cell carcinoma antigen (0.8723). The combined analysis of tested parameters and tumor markers resulted in an increase in sensitivity and areas under receiver operating characteristic curve values, which provides hope for developing new panel of biomarkers that may be used in the diagnosis of cervical cancer in the future." @default.
• W2883460805 created "2018-08-03" @default.
• W2883460805 creator A5006388276 @default.
• W2883460805 creator A5012697733 @default.
• W2883460805 creator A5031419790 @default.
• W2883460805 creator A5046740462 @default.
• W2883460805 creator A5052936358 @default.
• W2883460805 creator A5082530237 @default.
• W2883460805 creator A5086280225 @default.
• W2883460805 date "2018-07-27" @default.
• W2883460805 modified "2023-10-12" @default.
• W2883460805 title "Plasma levels and diagnostic utility of macrophage-colony stimulating factor, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 as tumor markers in cervical cancer patients" @default.
• W2883460805 cites W1488829562 @default.
• W2883460805 cites W1574172480 @default.
• W2883460805 cites W1905974666 @default.
• W2883460805 cites W1975132254 @default.
• W2883460805 cites W1976560584 @default.
• W2883460805 cites W1977512494 @default.
• W2883460805 cites W1993594806 @default.
• W2883460805 cites W2003500892 @default.
• W2883460805 cites W2014242905 @default.
• W2883460805 cites W2017830014 @default.
• W2883460805 cites W2017887265 @default.
• W2883460805 cites W2019994604 @default.
• W2883460805 cites W2020947105 @default.
• W2883460805 cites W2029963374 @default.
• W2883460805 cites W2043911483 @default.
• W2883460805 cites W2049177915 @default.
• W2883460805 cites W2057249449 @default.
• W2883460805 cites W2073660691 @default.
• W2883460805 cites W2086845458 @default.
• W2883460805 cites W2092743430 @default.
• W2883460805 cites W2101600093 @default.
• W2883460805 cites W2114796219 @default.
• W2883460805 cites W2122944628 @default.
• W2883460805 cites W2131464730 @default.
• W2883460805 cites W2138913064 @default.
• W2883460805 cites W2142719896 @default.
• W2883460805 cites W2276709339 @default.
• W2883460805 cites W2321323763 @default.
• W2883460805 cites W2460410077 @default.
• W2883460805 cites W2461242010 @default.
• W2883460805 cites W2518434407 @default.
• W2883460805 cites W2610340460 @default.
• W2883460805 cites W2703796845 @default.
• W2883460805 cites W2754379652 @default.
• W2883460805 cites W2917837889 @default.
• W2883460805 cites W588429005 @default.
• W2883460805 doi "https://doi.org/10.1177/1010428318790363" @default.
• W2883460805 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30052166" @default.
• W2883460805 hasPublicationYear "2018" @default.
• W2883460805 type Work @default.
• W2883460805 sameAs 2883460805 @default.
• W2883460805 citedByCount "8" @default.
• W2883460805 countsByYear W28834608052018 @default.
• W2883460805 countsByYear W28834608052019 @default.
• W2883460805 countsByYear W28834608052020 @default.
• W2883460805 countsByYear W28834608052021 @default.
• W2883460805 countsByYear W28834608052022 @default.
• W2883460805 crossrefType "journal-article" @default.
• W2883460805 hasAuthorship W2883460805A5006388276 @default.
• W2883460805 hasAuthorship W2883460805A5012697733 @default.
• W2883460805 hasAuthorship W2883460805A5031419790 @default.
• W2883460805 hasAuthorship W2883460805A5046740462 @default.
• W2883460805 hasAuthorship W2883460805A5052936358 @default.
• W2883460805 hasAuthorship W2883460805A5082530237 @default.
• W2883460805 hasAuthorship W2883460805A5086280225 @default.
• W2883460805 hasBestOaLocation W28834608051 @default.
• W2883460805 hasConcept C109523444 @default.
• W2883460805 hasConcept C121608353 @default.
• W2883460805 hasConcept C126322002 @default.
• W2883460805 hasConcept C142724271 @default.
• W2883460805 hasConcept C143998085 @default.
• W2883460805 hasConcept C147483822 @default.
• W2883460805 hasConcept C203014093 @default.
• W2883460805 hasConcept C2775965246 @default.
• W2883460805 hasConcept C2778220009 @default.
• W2883460805 hasConcept C71924100 @default.
• W2883460805 hasConcept C90924648 @default.
• W2883460805 hasConceptScore W2883460805C109523444 @default.
• W2883460805 hasConceptScore W2883460805C121608353 @default.
• W2883460805 hasConceptScore W2883460805C126322002 @default.
• W2883460805 hasConceptScore W2883460805C142724271 @default.
• W2883460805 hasConceptScore W2883460805C143998085 @default.
• W2883460805 hasConceptScore W2883460805C147483822 @default.
• W2883460805 hasConceptScore W2883460805C203014093 @default.
• W2883460805 hasConceptScore W2883460805C2775965246 @default.
• W2883460805 hasConceptScore W2883460805C2778220009 @default.
• W2883460805 hasConceptScore W2883460805C71924100 @default.
• W2883460805 hasConceptScore W2883460805C90924648 @default.
• W2883460805 hasFunder F4320322733 @default.
• W2883460805 hasIssue "7" @default.
• W2883460805 hasLocation W28834608051 @default.
• W2883460805 hasLocation W28834608052 @default.
• W2883460805 hasOpenAccess W2883460805 @default.
• W2883460805 hasPrimaryLocation W28834608051 @default.
• W2883460805 hasRelatedWork W1998885523 @default.
• W2883460805 hasRelatedWork W2064930914 @default.

• next